INTERNATIONAL PATENT: HOFSETH BIOCARE ASA, FRAMROZE, BOMI, CURRIE, CRAWFORD LINDEN ALEXANDER FILES APPLICATION FOR "ENHANCEMENT OF INCRETIN SIGNALLING AND PROMOTION OF PANCREATIC ISLET CELL HEALTH BY SOLUBLE PROTEIN HYDROLYSATE"

GENEVA, April 29 -- HOFSETH BIOCARE ASA (Kipervikgata 13N-6003 Alesund), FRAMROZE, Bomi (80 Valencia CtPortola Valley, California 94028), CURRIE, Crawford Linden Alexander (c/o Hofseth Biocare AsaKipervikgata 13N-6003 Alesund) filed a patent application (PCT/US2025/051491) for "ENHANCEMENT OF INCRETIN SIGNALLING AND PROMOTION OF PANCREATIC ISLET CELL HEALTH BY SOLUBLE PROTEIN HYDROLYSATE" on Oct 17, 2025. With publication no. WO/2026/085451, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOFSETH BIOCARE ASA (Kipervikgata...